Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Siegel, Jane D.
Rhinehart, Emily
Jackson, Marguerite
and
Chiarello, Linda
2007.
Management of multidrug-resistant organisms in health care settings, 2006.
American Journal of Infection Control,
Vol. 35,
Issue. 10,
p.
S165.
Hyle, Emily P.
Bilker, Warren B.
Gasink, Leanne B.
and
Lautenbach, Ebbing
2007.
Impact of Different Methods for Describing the Extent of Prior Antibiotic Exposure on the Association Between Antibiotic Use and Antibiotic-Resistant Infection.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 6,
p.
647.
Nadkarni, Abhijeet S.
Schliep, Tjark
Khan, Lamia
and
Zeana, Cosmina B.
2009.
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
American Journal of Infection Control,
Vol. 37,
Issue. 2,
p.
121.
Stone, Patricia W
2009.
Economic burden of healthcare-associated infections: an American perspective.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 9,
Issue. 5,
p.
417.
Cerceo, Elizabeth
Lautenbach, Ebbing
Linkin, Darren R.
Bilker, Warren B.
and
Lee, Ingi
2009.
Role of Matching in Case-Control Studies of Antimicrobial Resistance.
Infection Control & Hospital Epidemiology,
Vol. 30,
Issue. 5,
p.
480.
Tseng, Shu-Hui
Lee, Chun-Ming
Lin, Tzou-Yien
Chang, Shan-Chwen
and
Chang, Feng-Yee
2011.
Emergence and spread of multi-drug resistant organisms: Think globally and act locally.
Journal of Microbiology, Immunology and Infection,
Vol. 44,
Issue. 3,
p.
157.
Qureshi, Z.A.
Paterson, D.L.
Peleg, A.Y.
Adams-Haduch, J.M.
Shutt, K.A.
Pakstis, D.L.
Sordillo, E.
Polsky, B.
Sandkovsky, G.
Bhussar, M.K.
and
Doi, Y.
2012.
Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.
Clinical Microbiology and Infection,
Vol. 18,
Issue. 9,
p.
887.
Nowak, Michael A.
Nelson, Robert E.
Breidenbach, Jesse L.
Thompson, Paul A.
and
Carson, Paul J.
2012.
Clinical and economic outcomes of a prospective antimicrobial stewardship program.
American Journal of Health-System Pharmacy,
Vol. 69,
Issue. 17,
p.
1500.
BENOIT, S. R.
ELLINGSON, K. D.
WATERMAN, S. H.
and
PEARSON, M. L.
2014.
Antimicrobial resistance in eight US hospitals along the US–Mexico border, 2000–2006.
Epidemiology and Infection,
Vol. 142,
Issue. 11,
p.
2378.
Abera, Bayeh
Kibret, Mulugeta
and
Mulu, Wondemagegn
2014.
Knowledge and beliefs on antimicrobial resistance among physicians and nurses in hospitals in Amhara Region, Ethiopia.
BMC Pharmacology and Toxicology,
Vol. 15,
Issue. 1,
Datta, Rupak
and
Juthani-Mehta, Manisha
2017.
Burden and Management of Multidrug-Resistant Organisms in Palliative Care.
Palliative Care: Research and Treatment,
Vol. 10,
Issue. ,
Jia, Huixue
Li, Weiguang
Hou, Tieying
Ma, Hongqiu
Yang, Yun
Wu, Anhua
Liu, Yunxi
Wen, Jianguo
Yang, Huai
Luo, Xiaoli
Xing, Yawei
Zhang, Weihong
Wu, Yinghong
Ding, Lili
Liu, Weiping
Lin, Ling
Li, Ying
Chen, Meilian
and
Li, Liuyi
2019.
The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China.
BioMed Research International,
Vol. 2019,
Issue. ,
p.
1.
Nagassar, Rajeev
Bridgelal-Nagassar, Roma
Harper, Lima
and
Daniel, Keston
2020.
A Pilot Study to Delineate Factors Contributing to Multi-Drug Resistant Organism (MDRO) Outbreak and Control at the Sangre Grande Hospital.
Caribbean Medical Journal,